Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Radiotherapy Bridging in Patients with R/R High-Grade Lymphoma Receiving CD19 CAR-T in the UK.

A. Kuhnl,G. Mikhaeel,A. A. Kirkwood,T. F. Menne,J. Frew,E. Tholouli,A. Patel, C. M. Besley, M. J. Beasley,A. L. Latif,N. O'Rourke, E. Nicholson,E. Alexander,S. Chaganti,A. M. Stevens, M. A. V. Marzolini,R. J. Johnson,R. Sanderson,S. Sivabalasingham,C. Roddie

International journal of radiation oncology, biology, physics（2021）

Cited 2|Views7
No score
Abstract
RT is a safe and effective bridging therapy prior to CD19 CART in lymphoma. In this large prospective real world national cohort with high proportion of advanced stage and high-risk features, RT bridging was given successfully with low dropout rate and excellent survival outcomes.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined